Quick Answer
ACHIEVE LIFE SCIENCES, INC. reported R&D Expense of $22.82 million for fiscal year 2024.
ACHIEVE LIFE SCIENCES, INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2024 | $22.82M | +44.3% |
| 2023 | $15.81M | -47.4% |
| 2022 | $30.08M | +25.5% |
| 2021 | $23.97M | +248.2% |
| 2020 | $6.88M | -28.9% |
| 2019 | $9.67M | +64.9% |
| 2018 | $5.87M | +89.2% |
| 2017 | $3.10M | +984.3% |
| 2016 | $286.0K | -98.9% |
| 2015 | $25.11M | -45.7% |
| 2014 | $46.22M | -16.4% |
| 2013 | $55.32M | +38.5% |
| 2012 | $39.95M | +85.3% |
| 2011 | $21.55M | +16.6% |
| 2010 | $18.48M | -8.5% |
| 2009 | $20.21M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.32M | -30.1% | -20.7% |
| June 30, 2025 | $6.71M | +31.2% | -5.5% |
| March 31, 2025 | $7.10M | +153.6% | -6.7% |
| September 30, 2024 | $7.61M | +112.5% | +48.8% |
| June 30, 2024 | $5.11M | +11.5% | +82.7% |
| March 31, 2024 | $2.80M | -49.4% | -21.8% |
| September 30, 2023 | $3.58M | -63.7% | -21.9% |
| June 30, 2023 | $4.58M | -36.4% | -17.1% |
- ACHIEVE LIFE SCIENCES, INC. showed an increase of +44.3% in R&D Expense compared to the prior fiscal year.
- Over the 2009–2024 period, ACHIEVE LIFE SCIENCES, INC.’s r&d expense has grown by 12.9% (from $20.21 million to $22.82 million).
- The most recent figure is from ACHIEVE LIFE SCIENCES, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 11, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: